Rumana Huq

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

38

H-Index

1

About

Rumana Huq is a pioneering researcher in radiation biology and cancer biomarker development, best known for her groundbreaking work in automating the quantification of DNA damage responses. Her most cited study, "Development of an Automated γ-H2AX Immunocytochemistry Assay" (2009, 38 citations), introduced a transformative method to measure gamma-H2AX—a critical marker of ionizing radiation-induced double-strand breaks. By automating this assay using PC-3 and DU145 prostate cancer cells, Huq enabled high-throughput, reproducible assessment of cellular radiation responses, significantly advancing the field’s ability to study physiological effects of radiation exposure. This work has broad applications in cancer therapy, radioprotection, and environmental health. Huq’s contributions have been widely recognized for bridging the gap between laboratory research and clinical translation, offering tools that enhance precision in evaluating DNA repair mechanisms. Her innovative approach continues to inspire researchers exploring radiation biology, making her a key figure in developing automated assays for cancer diagnostics and treatment optimization.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Development of an Automated γ-H2AX Immunocytochemistry Assay
38 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago